(NASDAQ: AHCO) Adapthealth's forecast annual revenue growth rate of 5.26% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.67%.
Adapthealth's revenue in 2025 is $3,255,213,000.On average, 10 Wall Street analysts forecast AHCO's revenue for 2025 to be $446,358,604,864, with the lowest AHCO revenue forecast at $426,857,500,768, and the highest AHCO revenue forecast at $462,338,676,276. On average, 10 Wall Street analysts forecast AHCO's revenue for 2026 to be $475,339,412,340, with the lowest AHCO revenue forecast at $451,504,729,556, and the highest AHCO revenue forecast at $491,184,059,418.
In 2027, AHCO is forecast to generate $516,914,682,878 in revenue, with the lowest revenue forecast at $481,975,204,706 and the highest revenue forecast at $563,500,653,774.